The Munster Heart Study (PROCAM): Total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers

Circulation

Volumn 96, Issue 7, 1997, Pages 2128-2136

  Cullen, Paul ^b   Schulte, Helmut ^b   Assmann, Gerd ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE

Author keywords

Cholesterol; Coronary heart disease; Lipoproteins; Mortality; Smoking

Indexed keywords

CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CIGARETTE SMOKING; CORONARY RISK; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEATH; AGED; BLOOD; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; GERMANY; HEART INFARCTION; MIDDLE AGED; MULTICENTER STUDY; QUESTIONNAIRE; REFERENCE VALUE; SMOKING;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CEREBROVASCULAR DISORDERS; CHOLESTEROL, LDL; DEATH, SUDDEN, CARDIAC; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; QUESTIONNAIRES; REFERENCE VALUES; RISK FACTORS; SMOKING;

EID: 0030611999     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.7.2128     Document Type: Article

References (88)

1. Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Sherwin R, Shih J, Stamler J, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med. 1992;152:1490-1500.
2. Law MR, Wald NJ, Wu T, Hackshaw A, Bailey A. Systematic underestimation of association between serum cholesterol concentration and ischemic heart disease in observational studies: data from the BUPA Study. BMJ. 1994;308:363-366.
3. Pekkanen J, Nissinen A, Punsar S, Karvonen MJ. Short- and long-term association of serum cholesterol with mortality: the 25-year follow-up of the Finnish cohorts of the Seven Countries Study. Am J Epidemiol. 1992;135:1251-1258.
4. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA. 1987;257: 2176-2180.
5. Assmann G, Schulte H. Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Munster Study. Am J Cardiol. 1992;70:10H-13H.
6. Wilson PFW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality: the Framingham Study. Arteriosclerosis. 1988;8:737-741.
7. Williams RR, Sorlie PD, Feinleib M, McNamara PM, Kannel WB, Dawber TR. Cancer incidence by levels of cholesterol. JAMA. 1981; 245:247-252.
8. Garcia-Palmieri MR, Sorlie PD, Costas R, Havlik RJ. An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico. Am J Epidemiol. 1981;114:29-40.
9. Kozarevic D, McGee D, Vojvodic N, Gordon T, Racic Z, Zukel W, Dawber T. Serum cholesterol and mortality: the Yugoslavia Cardiovascular Disease Study. Am J Epidemiol. 1981;114:21-28.
10. Salmond CE, Beaglehole R, Prior IAM. Are low cholesterol values associated with excess mortality? BMJ. 1985;290:422-424.
11. Martin MJ, Browner WS, Wentworth D, Hulley SB, Kuller LH. Serum cholesterol, blood-pressure, and mortality: implications from a cohort of 361 662 men. Lancet. 1986;2:933-936.
12. Isles CG, Hole DJ, Gillis CR, Hawthorne VM, Lever AF. Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley Survey. BMJ. 1989;298:920-924.
13. Kagan A, McGee DL, Yano K, Rhoads GG, Nomura A. Serum cholesterol and mortality in a Japanese American population: the Honolulu Heart Program. Am J Epidemiol. 1981;114:11-20.
14. Stemmermann GN, Chyou PH, Kagan A, Nomura AMY, Yano K. Serum cholesterol and mortality among Japanese-American men: the Honolulu (Hawaii) Heart Program. Arch Intern Med. 1991;151: 969-972.
15. Frank JW, Reed DM, Grove JS, Benfante R. Will lowering population levels of serum-cholesterol affect total mortality? Expectations from the Honolulu Heart Program. J Clin Epidemiol. 1992; 45:333-346.
16. Kark JD, Smith AH, Hames CG. The relationship of serum cholesterol to the incidence of cancer in Evans County, Georgia. J Chron Dis. 1980;33:311-322.
17. White AD, Hames CG, Tyroler HA. Serum cholesterol and 20-year mortality in black and white men and women aged 65 and older in the Evans County Study. Ann Epidemiol. 1992;2:85-91.
18. Higgins M, Keller JB. Cholesterol, coronary heart disease, and total mortality in middle-aged and elderly men and women in Tecumseh. Ann Epidemiol. 1992;2:69-76.
19. Harris T, Feldman JJ, Kleinman JC, Ettinger WH, Makuc DM, Schatzkin AG. The low cholesterol mortality association in a national cohort. J Clin Epidemiol. 1992;45:595-601.
20. Schatzkin A, Taylor PR, Carter CL, Licitra LM, Hoover RN, Ziegler RG, Larson DB. Serum cholesterol and cancer in the NHANES-I epidemiologic follow-up study. Lancet. 1987;2:298-301.
21. Schatzkin AS, Hoover RN, Taylor PR, Ziegler RG, Carter CL, Albanes D, Larson DB, Licitra LM. Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Cancer Res. 1988;48:452-458.
22. Cowan LD, Oconnell DL, Criqui MH, Barrettconnor E, Bush TL, Wallace RB. Cancer mortality and lipid and lipoprotein levels: the Lipid Research Clinics Program mortality follow-up study. Am J Epidemiol. 1990;131:468-482.
23. Iso H, Naito Y, Kitamura A, Sato S, Kiyama M, Takayama Y, Iida M, Shimamoto T, Sankai T, Komachi Y. Serum total cholesterol and mortality in a Japanese population. J Clin Epidemiol. 1994;47: 961-969.
24. Goldbourt U, Yaari S, Neufeld HN. High density lipoprotein and total cholesterol as predictors of 7-year mortality from coronary heart disease, cancer and all causes. Am J Cardiol. 1981;47:486.
25. Smith GD, Shipley MJ, Marmot MG, Rose G. Plasma cholesterol concentration and mortality: the Whitehall Study. JAMA. 1992;267: 70-76.
26. Rose G, Shipley MJ. Plasma lipids and mortality: a source of error. Lancet. 1980;1:523-526.
27. Yaari S, Goldbourt U, Evenzohar S, Neufeld HN. Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10 000 men. Lancet. 1981;1:1011-1015.
28. Dyer AR, Stamler J, Paul O, Shekelle RB, Schoenberger JA, Berkson DM, Lepper M, Collette P, Shekelle S, Lindberg HA. Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies. J Chron Dis. 1981;34: 249-260.
29. Peterson B, Trell E, Sternby NH. Low cholesterol level as risk factor for non-coronary death in middle-aged men. JAMA. 1981; 245:2056-2057.
30. Schuit AJ, Van Dijk CEMJ, Dekker JM, Schouten EG, Kok FJ. Inverse association between serum total cholesterol and cancer mortality in Dutch civil servants. Am J Epidemiol. 1993;137:966-976.
31. Wald NJ, Thompson SG, Law MR, Densem JW, Bailey A. Serum cholesterol and subsequent risk of cancer: results from the BUPA Study. Br J Cancer. 1989;59:936-938.
32. Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY, Levine DM. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 1993;328:313-318.
33. Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R. Relationship of base line major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology. 1993;82:191-222.
34. Stamler J, Garside D, Dyer A, Stamler R, Liu K, Greenland P. The strong positive relationship of serum cholesterol to risk of death from coronary heart disease (CHD), all cardiovascular diseases (CVD), cancers, other diseases, and all causes in employed young adult men: findings of the Chicago Heart Association study (CHA). Circulation. 1993;88(suppl I):I-24. Abstract.
35. Stamler J, Garside D, Stamler R, Dyer A, Greenland P, Liu K, Ruth KJ. Low risk women and men: 19 year mortality data, Chicago Heart Association detection project in industry (CHA). Circulation. 1994;89:938.
36. Heady JA, Morris JN, Oliver MF. WHO clofibrate/cholesterol trial: clarifications. Lancet. 1992;340:1405-1406. Letter.
37. Stamler J, Neaton JD, Wentworth D. Mortality of low risk and other men: 16-year follow-up of 353 340 men screened for the Multiple Risk Factor Intervention Trial (MRFIT). Circulation. 1994;89:938. Abstract.
38. Strandberg TE, Salomaa VV, Naukkarinen VA, Vanhanen HT, Sarna SJ, Miettinen TA. Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. JAMA. 1991;266:1225-1229.
39. Multiple Risk Factor Intervention Trial Research Group. Risk factor changes and mortality results. JAMA. 1982;248:1465-1477.
40. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a qualitative review of primary prevention trials. BMJ. 1990;301:309-314.
41. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, Mäenpää H, Mälkönen M, Mänttäri M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjöblom T, Nikkilä EA. Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med. 1987;317:1237-1245.
42. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344: 1383-1389.
43. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New E J Med. 1995;333:1301-1307.
44. Simes RJ. Low cholesterol and risk of non-coronary mortality. Aust N Z J Med. 1994;24:113-119.
45. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, Neaton J, Nelson J, Potter J, Rifkind B, Rossouw J, Shekelle R, Yusuf S. Report of the conference on low blood cholesterol-mortality associations. Circulation. 1992;86:1046-1060.
46. Cummings P, Psaty BM. The association between cholesterol and death from injury. Ann Intern Med. 1994;120:848-855.
47. Law MR, Thompson SG, Wald NJ. Assessing possible hazards of reducing serum cholesterol. BMJ. 1994;308:373-379.
48. Davey-Smith G, Shipley MJ, Marmot MG, Rose G. Plasma cholesterol and mortality: the Whitehall Study. JAMA. 1992;267:70-76.
49. Manolio TA, Ettinger WH, Tracy RP, Kuller LH, Borhani NO, Lynch JC, Fried LP, Burke GL, Cody ME, Cruise RG, Furberg CD, Heiss G, Klopfenstein HS, Lefkowitz DS, Lyles MF, Mittelmark MB, Tell GS, Toole JF, Bommer W, Lee M, Robbins J, Schenker M, Bryan RN, Bush TL, Chabot J, Comstock GW, German PS, Hill J, Kittner SJ, Kumanyika S, Powe NR, Price TR, Rock R, Szklo M, Bonk J, Mclaughlin B, Meyer P, Newman A, Orchard TJ, Rutan GH, Schulz R, Smith VE, Wolfson SK, Antonculver H, Gardin JM, Knoll M, Kurosaki T, Wong N, Oleary DH, Polak JF, Potter J, Bovill E, Cornell E, Howard P, Enright P, Toogood S, Calhoun K, Calhoun H, Montague P, Rautaharju F, Rautaharju P, Fitzpatrick AL, Hermanson BK, Kronmal RA, Psaty BM, Siscovick DS, Shemanski L, Wahl PW, Bild DE, Savage PJ, Smith P. Epidemiology of low cholesterol levels in older adults: the Cardiovascular Health Study. Circulation. 1993;87:728-737.
50. Wannamethee G, Shaper AG. Blood lipids: the relationship with alcohol intake, smoking and body weight. J Epidemiol Commun Health. 1993;46:197-202.
51. Winawer SJ, Flehinger BJ, Buchalter J, Herbert E, Shike M. Declining serum cholesterol levels prior to diagnosis of colon cancer. JAMA. 1990;263:2083-2085.
52. McMichael AJ, Jensen OM, Parkin DM, Zaridze DG. Dietary and endogenous cholesterol and human cancer. Epidemiol Rev. 1984;6: 192-216.
53. Shorposner G, Basit A, Lu Y, Cabrejos C, Chang J, Fletcher M, Manteroatienza E, Baum MK. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med. 1993;94:515-519.
54. Constans J, Pellegrin JL, Peuchant E, Dumon MF, Pellegrin I, Sergeant C, Simonoff M, Brossard G, Barbeau P, Fleury H, Clerc M, Leng B, Conri C. Plasma lipids in HIV-infected patients: a prospective study in ninety-five patients. Eur J Clin Invest. 1994;24: 416-420.
55. Christeff N, Lortholary O, Casassus P, Thobie N, Dalle MT, Veyssier P, Guillevin L, Nunez EA. Serum lipid concentration with reference to the clinical and immunological status of HIV-infected men. Ann Med Intern. 1995;146:490-495.
56. Wannamethee G, Shaper AG, Whincup PH, Walker M. Low serum total cholesterol concentrations and mortality in middle aged British men. BMJ. 1995;311:409-413.
57. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem. 1964;6: 24-29.
58. Röschlau P, Bernt E, Gruber Z. Enzymatische Bestimmung des Gesamtcholėsterins im Serum. Z Klin Chem Klin Biochem. 1974; 12:403-408.
59. Burstein M, Samaille J. Sur un dosage rapide du cholesterol lié aux alpha- et aux betalipoproteins du sérum. Clin Chim Acta. 1960;5: 609-614.
60. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957;17:237-246.
61. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated levels of lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol. 1996;77: 1179-1184.
62. Lewis B, Tikkanen MJ. Low blood total cholesterol and mortality: causality, consequence and confounders. Am J Cardiol. 1994;73:80-85.
63. Freedman DS, Byers T, Barrett DH, Stroup NE, Eaker E, Monroeblum H. Plasma lipid levels and psychosocial characteristics in men. Am J Epidemiol. 1995;141:507-517.
64. Fowkes FGR, Leng GC, Donnan PT, Deary IJ, Riemersma RA, Housley E. Serum cholesterol, triglycerides, and aggression in the general population. Lancet. 1992;2:995-998.
65. Morgan RE, Palinkas LA, Barrett-Connor EL, Wingard DL. Plasma cholesterol and depressive symptoms in older men. Lancet. 1993;341:75-79.
66. Lindberg G, Larsson G, Setterlind S, Rastam L. Serum lipids and mood in working men and women in Sweden. J Epidemiol Commun Health. 1994;48:360-363.
67. Virkkunen M. Serum cholesterol in antisocial personality. Neuropsychobiology. 1979;5:27-30.
68. Glueck CJ, Tieger M, Kunkel R, Hamer T, Tracy T, Speirs J. Hypercholesterolemia and affective disorders. Am J Med Sci. 1994; 308:218-225.
69. Muldoon MF, Matthews KA, Wing RR. Serum cholesterol and depression in women. Circulation. 1994;89(suppl I):I-6. Abstract.
70. Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JD, Regier DA. Lifetime prevention of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984;41:949-958.
71. Schuit AJ, Dekker JM, Schouten EG, Kok FJ. Low serum cholesterol and death due to accidents, violence, or suicide. Lancet. 1993;341:827. Letter.
72. Lindberg G, Rastam L, Gullberg B, Eklund GA. Low serum cholesterol concentration and short-term mortality from injuries in men and women. BMJ. 1992;305:277-279.
73. Oliver MF. Doubts about preventing coronary heart disease: multiple interventions in middle-aged men may do more harm than good. BMJ. 1992;304:393-394.
74. Smith GD, Pekkanen J. Should there be a moratorium on cholesterol-lowering drugs? BMJ. 1992;304:431-433.
75. Ravnskov U. Cholesterol-lowering trials in coronary heart disease: frequency of citation and outcome. BMJ. 1992;305:15-19.
76. Hodgkinson N. Cutting cholesterol increases danger of heart attacks: diet theories overturned by new research. The Sunday Times, 22 December 1991, page 1.
77. Anonymous. Freispruch für einen Schurken [A villain is acquitted]. Der Spiegel, issue 45, 1990, pages 256-272.
78. Moore TJ. The cholesterol myth. The Atlantic Monthly, September 1989, pages 37-69.
79. Prentice T. Heart pills can increase risk of death. The Irish Times, 14 February 1992, page 4.
80. d'Agostino RB, Belanger AJ, Kannel WB, Higgins M. Role of smoking in the U-shaped relation of cholesterol to mortality in men: the Framingham Study. Am J Epidemiol. 1995;141:822-827.
81. Iribarren C, Reed DM, Burchfiel CM, Dwyer JH. Serum total cholesterol and mortality: confounding factors and risk modification in Japanese-American men. JAMA. 1995;273:1926-1932.
82. Baptiste MS, Nasca PC, Doyle JT, Rothenberg RR, MacCubbin PA, Mettlin C, Metzger C, Carlton KA. Cholesterol and cancer in a population of male civil service workers. Int J Epidemiol. 1992; 21:16-22.
83. Law MR, Thompson SG. Low serum cholesterol and the risk of cancer: analysis of the published prospective studies. Cancer Causes Control. 1991;2:253-261.
84. Chen Z, Peto R, Collins R, Macmahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ. 1991;303:276-282.
85. Dietschy JM. Regulation of cholesterol metabolism in man and in other species. Klin Wochenschr. 1984;62:338-345.
86. Iribarren C, Sharp D, Burchfiel CM, Sun P, Dwyer JH. Association of serum total cholesterol with coronary disease and all- cause mortality: multivariate correction for bias due to measurement error. Am J Epidemiol. 1996;143:463-471.
87. Ettinger WH Jr, Harris TB. Cytokines cause hypocholesterolemia: a mechanism to explain the association of low cholesterol with mortality from multiple chronic diseases. Cardiovasc Risk Factors. 1995;5:173-179.
88. Puska P, Tuomilehto J, Salonen J, Nissinene A, Virtamo J, Björkqvist S, for the North Karelia Project. Community Control of Cardiovascular Diseases: The North Karelia Project. Copenhagen: WHO Regional Office for Europe; 1981.